# LivaNova closes $250M acquisition of TandemLife

LivaNova closed its $250 million acquisition of TandemLife, a developer of cardiopulmonary temporary support solutions. The deal included $200 million upfront and up to $50 million in milestone payments.

- Type: Acquisition
- Announced: 2018-04-06
- Value: $250.0M
- Status: completed
- Products: cardiopulmonary temporary support solutions, extracorporeal life support systems, percutaneous mechanical circulatory support systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [LivaNova](https://endata.com/companies/8038.md) (acquirer)
- [TandemLife](https://endata.com/companies/30056.md) (target)

## Sources

- [massdevice.com](https://www.massdevice.com/livanova-closes-250m-tandemlife-buy/), 2018-04-06: "The acquisition of TandemLife allows us to complement our portfolio with a complete set of solutions for extracorporeal life support and percutaneous mechanical circulatory support."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.